How to Identify Candidates for Peer CBT in Postpartum Depression
How do clinicians identify which mothers with postpartum depression are appropriate candidates for peer-delivered group cognitive-behavioral therapy?
Many mothers with postpartum depression do not receive evidence-based psychotherapy despite regular contact with health care providers in the postpartum period. This guide applies to clinicians considering referral to a structured peer-delivered group cognitive-behavioral therapy program for symptomatic mothers in the first postpartum year.
-
Confirm postpartum timing and basic eligibility
Identify mothers who are 18 years or older and have an infant younger than 12 months of age. In this trial, participants also had to be fluent in English, so the evidence directly applies to English-speaking mothers who can participate in that format.
-
Screen for depressive symptom burden with the EPDS
Use the Edinburgh Postnatal Depression Scale to identify mothers with clinically relevant postpartum depressive symptoms. The trial enrolled women with EPDS scores of 10 or higher, a threshold the authors used to capture possible depression and broaden access to care.
-
Rule out key exclusions with diagnostic assessment
Assess for bipolar disorder, psychotic disorders, and current substance use disorders before referral. In this study, women had to be free of these conditions on the Mini-International Neuropsychiatric Interview, so the intervention was tested only in mothers without those exclusions.
-
Assess comorbidity without excluding common anxiety disorders
Do not assume anxiety symptoms rule out referral. Generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder were common in the sample, and the intervention was associated with improvement in anxiety as well as postpartum depression.
-
Offer peer-delivered group CBT alongside usual care
Consider referral even if the patient is already receiving medication, psychotherapy, or other usual mental health care. Participants in both study groups were allowed to continue usual care during the trial, and there were no between-group changes in mental health visits or psychotropic medication use from baseline to 9 weeks.
-
Set expectations for likely outcomes and monitoring
Explain that the strongest short-term benefits observed were reductions in depressive and anxiety symptoms over 9 weeks. In the trial, a clinically meaningful depression response was defined as an EPDS decrease of 4 or more points, and participants randomized to treatment were more likely than controls to achieve that level of improvement and to no longer meet criteria for current major depressive disorder at 9 weeks.
Clinical Considerations
- The study only included women without bipolar disorder, psychotic disorders, or current substance use disorders, so applicability outside those criteria is unknown.
- The sample was relatively small, had substantial loss to follow-up, and had little ethnic diversity, which may limit generalizability.
- Participants were recruited in Canada and could access universal health care and other usual mental health services during the study.
- The trial found no short-term improvement in perceived social support or mother-infant relationship outcomes from baseline to 9 weeks.
Bottom Line
For postpartum patients within 12 months of delivery who have EPDS scores of 10 or higher and no bipolar, psychotic, or current substance use disorders, peer-delivered group cognitive-behavioral therapy is a reasonable referral option for reducing depression and anxiety symptoms.
